Immortalized cell

US2016348075A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016348075-A1
Application numberUS-201615236266-A
CountryUS
Kind codeA1
Filing dateAug 12, 2016
Priority dateFeb 14, 2014
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to an immortalized cell, an immortalized cell line comprising said immortalized cell, a cell culture comprising the immortalized cell or cell line, and a method for the production of an immortalized cell.

First claim

Opening claim text (preview).

Therefore, what is claimed is: 1 . Immortalized periosteum cell. 2 . Immortalized periosteum cell of claim 1 , which is a human immortalized periosteum cell. 3 . Immortalized periosteum cell of claim 1 , which is an immortalized cranium periosteum cell. 4 . Immortalized periosteum cell of claim 1 , which is osteogenically differentiable. 5 . Immortalized periosteum cell of claim 1 , which was deposited on 29 Nov. 2013 under the designation “Tag58” at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany (DSMZ) under the accession number DSM ACC3218. 6 . Immortalized periosteum cell line, which comprises the periosteum cell of claim 1 . 7 . Cell culture, which comprises the periosteum cell of claim 1 . 8 . Method for the production of an immortalized periosteum cell, comprising the following steps: 1. providing an isolated periosteum primary cell, and 2. immortalizing the periosteum primary cell for obtaining an immortalized periosteum cell. 9 . The method of claim 8 , wherein the immortalization occurs by transduction of the large T-antigen of the SV40 virus into the periosteum primary cell.

Assignees

Inventors

Classifications

  • Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

  • C12N5/0654Primary

    Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth · CPC title

  • viral genome or elements thereof as genetic vector · CPC title

  • Immortalised cells · CPC title

  • Adult fibroblasts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016348075A1 cover?
The present invention relates to an immortalized cell, an immortalized cell line comprising said immortalized cell, a cell culture comprising the immortalized cell or cell line, and a method for the production of an immortalized cell.
Who is the assignee on this patent?
Univ Tuebingen Medizinische Fakultaet
What technology area does this patent fall under?
Primary CPC classification C12N5/0654. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).